About EJOP

• To provide information on professional topics to practising oncology pharmacists and technicians
• To offer a publishing platform to share professional achievements
• To disseminate information on recent scientific progress and give scientific overviews on oncology, particularly oncology pharmacy matters where the knowledge has moved forward significantly
• To provide diagnostic, therapeutic, chemical, pharmacological, toxicological and chemical background specifically related to oncology pharmacy
• To offer a regular communication channel to ESOP members and others twice a year
• To strengthen the profile of ESOP members’ professional status

The European Journal of Oncology Pharmacy (EJOP), published twice a year, sets out to offer a professional communication platform to European oncology pharmacy practitioners. As the official journal of the European Society of Oncology Pharmacy (ESOP), the scope of EJOP is to satisfy ESOP members’ needs in terms of improvement on professional standard, setting guidelines, further education and sharing practice experience. EJOP offers ESOP members an insight into the differences and commonalities of oncology pharmacy standards and training, as well as the opportunities to learn the unique benefits and advantages from the different oncology pharmacy practitioners.

The diversified editorial content of EJOP provides a good source of information to its readers.

• Cover Story comprises a series of review articles on a current oncology treatment or medical advances from major international and European oncology meetings, e.g. ASCO, ECCO
• Oncology Pharmacy Practice offers multiple articles in various areas such as guidelines, stability of cancer drugs, treatment protocols, multidisciplinary collaboration practice in the healthcare setting, supportive care, patients’ rights and demands, radiopharmacy and chemotherapy
• New Drug Update introduces the drug/pharmaceutical innovations in cancer care
• Case Report describes in detail unusual or novel occurrences in the medical care of a patient, emphasising the influence the hospital pharmacist can have on the successful treatment of a health condition
• Conference or Meeting Report is the editorial section for members to share and exchange experiences, covering international conferences and national meetings
• Education offers an informative platform to share learning from educational workshops, exchange ideas and practices aiming to improve on the standard of care to cancer patients by oncology pharmacy practitioners
• News/Announcements is a section to share information on national and international events relevant to oncology pharmacy, and news on key national developments

Editorial Board of EJOP
Editor-in-Chief: Klaus Meier, Germany
Professor Alain Astier, France
Professor Per Hartvig, Sweden
Dr Robert Terkola, Austria
Professor Wolfgang Wagner, Germany
Professor Guenther Wiedemann, Germany

In January each year, the Editor-in-Chief, the Editorial Advisory Board members and the Publisher meet in Hamburg, Germany, to brainstorm and discuss the key topics and issues of relevance and interest to EJOP readers. In general, EJOP will cover the highlights of ASCO (international) and ESOP (European) congress.